Tian An Medicare Limited (TIANAN MEDICARE) filed its monthly return for the period ended 30 April 2026, confirming that all key share-capital metrics remained unchanged during the month.

Authorised Capital • The authorised share capital stayed at 30.00 billion ordinary shares with a par value of HKD 0.01 each, equivalent to HKD 300.00 million. • No increase or reduction was recorded in April.

Issued Shares and Treasury Position • Issued shares (excluding treasury shares) closed April at 1.08 billion, identical to the level at end-March. • The company held no treasury shares, and there were no share issuances, cancellations, or share buy-backs during the month.

Public Float Status • Tian An Medicare affirmed compliance with the Main Board’s minimum 25% public-float requirement as of 30 April 2026.

Share Option Scheme • Under the Share Option Scheme adopted on 7 March 2019, there were no outstanding or newly granted/exercised options in April. • The mandate still allows for up to 72.40 million shares to be issued upon future option exercises. • No capital was raised from option exercises during the month.

Overall, the April 2026 return indicates a period of capital stability for Tian An Medicare, with the share count, authorised capital, and treasury position all unchanged while maintaining regulatory compliance on public float.